Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-11-002000
Filing Date
2011-11-14
Accepted
2011-11-14 16:31:16
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 biostarpharma10q093011.htm 10-Q 1210886
2 ex31-1.htm EX-31.1 17182
3 ex31-2.htm EX-31.2 17401
4 ex32-1.htm EX-32.1 5786
5 ex32-2.htm EX-32.2 5725
  Complete submission text file 0001185185-11-002000.txt   3547733

Data Files

Seq Description Document Type Size
6 bspm-20110930.xml EX-101.INS 518968
7 bspm-20110930.xsd EX-101.SCH 18102
8 bspm-20110930_cal.xml EX-101.CAL 27235
9 bspm-20110930_def.xml EX-101.DEF 80415
10 bspm-20110930_lab.xml EX-101.LAB 108762
11 bspm-20110930_pre.xml EX-101.PRE 92478
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 1-646-623-6999
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

EIN.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 111203152
SIC: 2834 Pharmaceutical Preparations